Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

Company Overview - Journey Medical Corporation is a commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription pharmaceutical products for dermatological conditions [4] - The company currently markets eight branded FDA-approved prescription drugs aimed at treating common skin conditions [4] - Journey Medical was founded by Fortress Biotech, Inc. and is located in Scottsdale, Arizona [4] Financial Results Announcement - Journey Medical will release its year-end 2025 financial results after U.S. financial markets close on March 25, 2026 [1] - A conference call and audio webcast will be held on March 25, 2026, at 4:30 p.m. ET to discuss the financial results and provide a corporate update [1] Conference Call Details - Interested parties in the U.S. can dial 1-866-777-2509 for domestic calls or 1-412-317-5413 for international calls to join the conference call [2] - Participants are encouraged to dial in approximately 10 minutes prior to the scheduled start time [2] - A live audio webcast will be available on the Investors section of Journey Medical's website and will remain accessible for replay for about 30 days after the conference call [3]